| Entry |
|
|---|
| Name |
Inactivation of CaMKII by inducing SERCA2
|
|---|
| Definition |
MERTK -> ERK => SERCA2 -| CAMK2 |
|---|
| Expanded |
10461 -> (5594,5595) => 488 -| (815,816,817,818) |
|---|
| Class |
|
|---|
| Type |
Reference
|
|---|
| Pathway |
|
|---|
| Gene |
| 10461 | MERTK; MER proto-oncogene, tyrosine kinase |
| 5594 | MAPK1; mitogen-activated protein kinase 1 |
| 5595 | MAPK3; mitogen-activated protein kinase 3 |
| 488 | ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
| 815 | CAMK2A; calcium/calmodulin dependent protein kinase II alpha |
| 816 | CAMK2B; calcium/calmodulin dependent protein kinase II beta |
| 817 | CAMK2D; calcium/calmodulin dependent protein kinase II delta |
| 818 | CAMK2G; calcium/calmodulin dependent protein kinase II gamma |
|
|---|
| Reference |
|
|---|
| Authors |
Cai B, Kasikara C, Doran AC, Ramakrishnan R, Birge RB, Tabas I |
|---|
| Title |
MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M |
|---|
| Title |
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
